Cystic Fibrosis (CF) is the most common life-threatening genetic disorder affecting Australian children.
CF affects all parts of the body, but mainly damages the lungs and digestive system. Over time, the lungs become increasingly affected by inflammation and respiratory function is significantly reduced. There are a number of treatments available to reduce the problems caused by the condition, but average life expectancy is ultimately compromised. At present there is no cure.
We are particularly interested in how CF affects the respiratory, digestive and endocrine systems, and through our research in these areas we aim to find a cure for CF.
We are also involved in clinical trials to test the safety and efficacy of novel therapies and interventions for CF.